Earth Science Tech (ETST) Non-Current Assets (2014 - 2026)
Earth Science Tech (ETST) posted Non-Current Assets of $5.2 million for Q1 2026, up 3.79% on a QoQ basis from $5.1 million in Q4 2025, and up 32.66% year-over-year from $4.0 million in Q1 2025.
Earth Science Tech (ETST) Non-Current Assets (2014 - 2026) Analysis & Trends
Earth Science Tech's Non-Current Assets history runs 11 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- Quarterly Non-Current Assets rose 32.66% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 million (up 52.95% YoY) and the FY2026 annual result came in at $5.2 million, up 32.66% from the prior year.
- Non-Current Assets was $5.2 million for Q1 2026 at Earth Science Tech, up from $5.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $5.2 million in Q1 2026 and bottomed at $50000.0 in Q1 2022.
- A 5-year average of $2.8 million and a median of $2.7 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 5626.97% — and 2024, when it retreated 2.19%.
- Earth Science Tech's Non-Current Assets stood at $513188.0 in 2022, then surged by 400.77% to $2.6 million in 2023, then surged by 44.08% to $3.7 million in 2024, then jumped by 36.56% to $5.1 million in 2025, then rose by 3.79% to $5.2 million in 2026.
- Business Quant data shows ETST's Non-Current Assets at $5.2 million in Q1 2026, $5.1 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 5.06 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.75 Mn |
| Mar 31, 2023 | 2.68 Mn |
| Dec 31, 2022 | 513,188.00 |
| Sep 30, 2022 | 354,557.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Sep 30, 2021 | 6,191.00 |
| Jun 30, 2021 | 6,191.00 |
| Mar 31, 2021 | 20,556.00 |